About CSSI
The Center for Strategic Scientific Initiatives (CSSI) creates opportunities for researchers through the development of new science initiatives, tools, and public resources to accelerate progress in cancer research.
In the era of precision medicine, human epidermal growth factor receptor 2 (HER2) is one of the important predictive and prognostic biomarkers in breast cancer. At present, conventional HER2-targeting therapies improve outcomes for patients with HER2-positive breast cancer, defined as tumors...